陽光城(000671.SZ):泰康人壽及泰康養老擬受讓13.53%的股份
格隆匯 9 月 9日丨陽光城(000671.SZ)公佈,2020年9月9日,公司收到公司第二大股東上海嘉聞投資管理有限公司(“上海嘉聞”)的通知,上海嘉聞與泰康人壽保險有限責任公司(“泰康人壽”)及泰康養老保險股份有限公司(“泰康養老”)簽訂《股權轉讓協議》,約定泰康人壽及泰康養老通過協議受讓的方式,從上海嘉聞受讓公司13.53%的股份,共計554,710,264股,此次協議轉讓不觸及要約收購。
此次股份轉讓的單價為6.09元/股(含税),標的股份轉讓價款約33.78億元(含税)。
同日,上海嘉聞通過大宗交易減持其持有的公司4100.3391萬股無限售流通股股份,佔公司總股本的1.00%。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.